Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus?

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4589-4600

  Angulo, Ana ^a   Chandraratna, Roshantha A S ^b   LeBlanc, James F ^a   Ghazal, Peter ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; 4 [5,6 DIHYDRO 5,5 DIMETHYL 8 ((4 METHYLPHENYL) 2 NAPHTHALENYL) ETHYNYL]BENZOIC ACID; ALITRETINOIN; BEXAROTENE; LG 100069; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ANTAGONIST; RETINOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISSOCIATION CONSTANT; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOCOMPETENCE; LIGAND BINDING; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031925675     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4589-4600.1998     Document Type: Article

References (54)

1. Achkar, C. C., J. M. Bentel, J. F. Boylan, H. I. Scher, L. J. Gudas, and W. H. J. Miller. 1994. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metab. Dispos. 22:451-458.
2. Agarwal, C., R. A. S. Chandraratna, A. T. Johnson, E. A. Rorke, and R. L. Eckert. 1996. AGN 193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J. Biol. Chem. 271:12209-12212.
3. Angulo, A., C. Suto, M. F. Boehm, R. A. Heyman, and P. Ghazal. 1995. Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69:3831-3837.
4. Angulo, A., and P. Ghazal. 1995. Regulation of human cytomegalovirus by retinoic acid. Scand. J. Infect. Dis. 99:113-115.
5. Angulo, A., and P. Ghazal. Unpublished data.
6. Angulo, A., C. Suto, R. A. Heyman, and P. Ghazal. 1996. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol. Endocrinol. 10: 781-793.
7. Apfel, C., F. Bauer, M. Crettaz, L. Forni, M. Kamber, F. Kaufmann, P. LeMotte, W. Pirson, and M. Klaus. 1992. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. USA 89:7129-7133.
8. Baskar, J. F., P. P. Smith, G. S. Ciment, S. Hoffman, C. Tucker, D. J. Tenney, A. M. Colberg-Poley, J. A. Nelson, and P. Ghazal. 1996. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:3215-3226.
9. Baskar, J. F., P. P. Smith, N. Gajanan, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
10. 3H]-9-cis-retinoic acid and its application for identifying unusual binding properties. J. Med. Chem. 37:408-414.
11. Cardin, R. D., G. B. Abenes, C. A. Stoddart, and E. S. Mocarski. 1995. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236-241.
12. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
13. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
14. Cox, D. R., and E. J. Snell. 1989. Analysis of binary data, 2nd ed. Chapman and Hall, London, United Kingdom.
15. Dorsch-Hasler, K., G. M. Keil, F. Weber, M. Jasin, W. Schaffner, and U. H. Koszinowski. 1985. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murme cytomegalovirus. Proc. Natl. Acad. Sci. USA 82:8325-8329.
16. Eckhardt, K., and G. Schmitt. 1994. A retinoic acid receptor α antagonist counteracts retinoid teratogenicity in vitro and reduces incidence and/or severity of malformations in vivo. Toxicol. Lett. 70:299-308.
17. Eyrolles, L., H. Kagechika, E. Kawachi, H. Fukasawa, T. Lijima, Y. Matsushima, Y. Hashimoto, and K. Shudo. 1994. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring. J. Med. Chem. 37:1508-1517.
18. Garcia, A. D., P. Ostapchuk, and P. Hearing. 1993. Functional interaction of nuclear factors EF-C, HNF-4, and RXRa with hepatitis B virus enhancer I. J. Virol. 67:3940-3950.
19. Ghazal, P., C. DeMattei, E. Giulietti, S. A. Kliewer, K. Umesono, and R. M. Evans. 1992. Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc. Natl. Acad. Sci. USA 89:7630-7634.
20. Ghazal, P., J. LeBlanc, and A. Angulo. 1997. Vitamin A regulation of viral growth. Rev. Med. Virol. 7:21-34.
21. Gonczol, E., P. W. Andrews, and S. A. Plotkin. 1984. Cytomegalovirus replicates in differentiated but not undifferentiated human embryonal carcinoma cells. Science 224:159-161.
22. Heieren, H. H., Y. Kim, and H. H. Balfour. 1988. Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation 46:426-432.
23. Johnson, A. T., E. S. Klein, S. J. Gillett, L. Wang, T. K. Song, M. E. Pino, and R. A. S. Chandraratna. 1995. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 38:4764-4767.
24. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
25. Klein, E. S., M. E. Pino, A. T. Johnson, P. J. A. Davies, S. Nagpal, S. M. Thacher, G. Krasinski, and R. A. S. Chandraratna. 1996. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J. Biol. Chem. 271:22692-22696.
26. Koedood, M., A. Fichtel, P. Meier, and P. J. Mitchell. 1995. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:2194-2207.
27. Koszinowski, U. H., M. J. Reddehase, and M. Del Val. 1992. Principles of cytomegalovirus antigen presentation in vitro and in vivo. Semin. Immunol. 4:71-79.
28. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531.
29. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
30. Lafemina, R., and G. Hayward. 1986. Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells. J. Virol. 58:434-440.
31. Lee, M. O., M. I. Dawson, N. Picard, P. D. Hobbs, and M. Pfahl. 1996. A novel class of retinoid antagonists and their mechanism of action. J. Biol. Chem. 271:11897-11903.
32. Lindamood, C., III, F. O. Cope, D. L. Dillehay, M. P. Everson, H. D. Giles, E. W. Lamon, D. J. McCarthy, J. L. Sartin, and D. L. Hill. 1990. Pharmacological and toxicological properties of arotinoids SMR-2 and SMR-6 in mice. Fundam. Appl. Toxicol. 14:15-29.
33. Loeliger, P., W. Bollag, and H. Mayer. 1980. Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. Chim. Ther. 15:9-15.
34. Mangelsdorf, D. J., K. Umesono, and R. M. Evans. 1994. The retinoid receptors, p. 319-349. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.) The retinoids: biology, chemistry, and medicine. Raven Press, New York, N.Y.
35. Manning, W. C., and E. S. Mocarski. 1988. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent α gene (ie2) is dispensable for growth. Virology 167:477-484.
36. McGeoch, D. J., S. Cook, A. Dolan, F. E. Jamieson, and E. A. R. Telford. 1995. Molecular phylogeny and evolutionary timescale for the family of mamalian herpesviruses. J. Mol. Biol. 247:443-458.
37. Mims, C. A., and J. Gould. 1978. Splenic necrosis in mice infected with cytomegalovirus. J. Infect. Dis. 137:587-591.
38. 491aa replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA 93:11321-11326.
39. Moens, U., N. Subramaniam, B. Johansen, T. Johansen, and T. Traavik. 1994. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J. Virol. 68:2398-2408.
40. Nelson, J. A., and M. Groudine. 1986. Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol. Cell. Biol. 6:452-461.
41. Payvar, F., D. DeFranco, G. L. Firestone, B. Edgar, O. Wrange, S. Okret, J.-A. Gustafsson, and K. R. Yamamoto. 1983. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35:381-392.
42. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
43. Ringold, G. M., K. R. Yamamoto, G. M. Tomkins, J. M. Bishop, and H. E. Varmus. 1975. Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action. Cell 6:299-305.
44. Segars, J. H., T. Nagata, V. Bours. J. A. Medin, G. Franzoso, J. C. G. Blanco, P. D. Drew, K. G. Becker, J. An, T. Tang, D. A. Stephany, B. Neel, U. Siebenlist, and K. Ozato. 1993. Retinoic acid induction of major histocompatibility complex class I in NTera-2 embryonal carcinoma cells involves induction of NF-kB (p50-p65) and retinoic acid receptor β-retinoid X receptor β heterodimers. Mol. Cell. Biol. 13:6157-6169.
45. Standeven, A. M., R. L. Beard, A. T. Johnson, M. F. Boehm, M. Escobar, R. A. Heyman, and R. A. S. Chandraratna. 1996. Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam. Appl. Toxicol. 33:264-271.
46. Standeven, A. M., P. J. A. Davies, R. A. S. Chandraratna, D. R. Mader, A. T. Johnson, and V. A. Thomazy. 1996. Retinoid-induced epiphyseal plate closure in guinea pigs. Fund. Appl. Toxicol. 34:91-98.
47. Standeven, A. M., A. T. Johnson, M. Escobar, and R. A. S. Chandraratna. 1996. Specific antagonist of retinoid toxicity in mice. Toxicol. Appl. Pharmacol. 138:169-175.
48. Stoddart, C. A., R. D. Cardin, J. M. Boname, W. C. Manning, G. B. Abenes, and E. S. Mocarski. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:6243-6253.
49. Sucov, H. M., K. K. Murakami, and R. M. Evans. 1990. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc. Natl. Acad. Sci. USA 87:5392-5396.
50. Wade, P. A., and A. P. Wolffe. 1997. Chromatin: histone acetyltransferases in control. Curr. Biol. 7:82-84.
51. Wolff, D., C. Sinzger, P. Drescher, G. Jahn, and B. Plachter. 1994. Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus. Virology 204:101-113.
52. Yoshimura, H., M. Nagai, S. Hibi, K. Kikuchi, S. Abe, T. Hida, S. Higashi, I. Hishinuma, and T. Yamanaka. 1995. A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives. J. Med. Chem. 38:3163-3173.
53. Zuo, F., and J. E. Mertz. 1995. SV40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily Proc. Natl. Acad. Sci. USA 92:8586-8590.
54. Zuo, F., R. J. Kraus, T. Gulick, D. D. Moore, and J. E. Mertz. 1997. Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor. J. Virol. 71:427-436.